000280248 001__ 280248
000280248 005__ 20250828101648.0
000280248 0247_ $$2doi$$a10.1016/j.bbih.2025.101064
000280248 0247_ $$2pmid$$apmid:40746968
000280248 0247_ $$2pmc$$apmc:PMC12312059
000280248 037__ $$aDZNE-2025-00926
000280248 041__ $$aEnglish
000280248 082__ $$a610
000280248 1001_ $$aWeiser, Judith$$b0
000280248 245__ $$aSocial anxiety disorder and antibodies against glial cells in the cerebrospinal fluid.
000280248 260__ $$a[Amsterdam]$$bElsevier B.V.$$c2025
000280248 3367_ $$2DRIVER$$aarticle
000280248 3367_ $$2DataCite$$aOutput Types/Journal article
000280248 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756205762_31523
000280248 3367_ $$2BibTeX$$aARTICLE
000280248 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000280248 3367_ $$00$$2EndNote$$aJournal Article
000280248 520__ $$aAutoimmune social anxiety disorders have not yet been described in the literature.Therefore, this case of a patient with possible autoimmune-mediated social anxiety disorder is presented. Due to treatment resistance and high serum streptococcal antibody levels, a comprehensive diagnostic work-up was performed.The 19-year-old female patient presented with predominant social anxiety disorder and secondary depression. Testing for all known characterized neuronal and glial IgG antibodies identified slightly positive ('+') recoverin IgG antibodies only in the serum (using an immunoassay). Cerebrospinal fluid (CSF) analysis using a tissue-based assay on unfixed mouse brain slices revealed moderate immunoglobulin G (IgG) anti-nuclear binding and a specific strong IgG binding against cell nuclei of the Bergmann glia in the cerebellum. No clear pathology was noted in conventional magnetic resonance imaging (MRI), voxel-based morphometry, and cerebral blood flow. Diffusion microstructure imaging (DMI) revealed a substantial reduction of the intraneurite volume fraction in the cerebellar gray and white matter. This was accompanied by a compensatory increase in free fluid and the extra-neurite volume fraction. Alterations in the striatum were also observed with DMI. Electroencephalography (EEG) showed intermittent generalized slowing with underlying left frontal, right temporal, and left temporo-occipital components (detected via independent component analysis of the EEG). The [18F]fluorodeoxyglucose positron emission tomography of the whole body detected a slight polyserositis and no malignant tumor.This is the first description of a case with evidence of a possible antibody-mediated cerebellar dysfunction associated with social anxiety disorder. The testing for all characterized neuronal/glial antibodies showed only weakly positive recoverin antibodies in the serum, which, however, were not detectable in the CSF. Therefore, novel CSF antibodies directed against cell nuclei of the Bergmann glia in the cerebellum could be assumed. DMI alterations in the cerebellum were in principle compatible with neuroinflammation with edematization and cellular activation. In addition, the further DMI alterations in the striatum and the fronto-temporal generators of EEG slowing suggest an involvement of the 'anxiety network'. Further immunopsychiatric research in anxiety disorders might contribute to identifying an autoimmune subtype and potentially immunomodulatory treatment options.
000280248 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000280248 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000280248 650_7 $$2Other$$aAnxiety
000280248 650_7 $$2Other$$aAutoimmune
000280248 650_7 $$2Other$$aInflammation
000280248 650_7 $$2Other$$aRecoverin
000280248 650_7 $$2Other$$aSocial phobia
000280248 7001_ $$aRau, Alexander$$b1
000280248 7001_ $$avon Zedtwitz, Katharina$$b2
000280248 7001_ $$aFeige, Bernd$$b3
000280248 7001_ $$aNickel, Kathrin$$b4
000280248 7001_ $$aMaier, Simon J$$b5
000280248 7001_ $$aDressle, Raphael J$$b6
000280248 7001_ $$aVenhoff, Nils$$b7
000280248 7001_ $$avan Elst, Ludger Tebartz$$b8
000280248 7001_ $$aSchiele, Miriam A$$b9
000280248 7001_ $$aDomschke, Katharina$$b10
000280248 7001_ $$0P:(DE-2719)2810931$$aPrüss, Harald$$b11$$udzne
000280248 7001_ $$aEndres, Dominique$$b12
000280248 773__ $$0PERI:(DE-600)3062237-2$$a10.1016/j.bbih.2025.101064$$gVol. 48, p. 101064 -$$p101064$$tBrain, behavior, & immunity - health$$v48$$x2666-3546$$y2025
000280248 8564_ $$uhttps://pub.dzne.de/record/280248/files/DZNE-2025-00926.pdf$$yOpenAccess
000280248 8564_ $$uhttps://pub.dzne.de/record/280248/files/DZNE-2025-00926.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000280248 909CO $$ooai:pub.dzne.de:280248$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000280248 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810931$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b11$$kDZNE
000280248 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000280248 9141_ $$y2025
000280248 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-02
000280248 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000280248 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-12-02T13:23:11Z
000280248 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-12-02T13:23:11Z
000280248 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000280248 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2021-12-02T13:23:11Z
000280248 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000280248 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
000280248 9201_ $$0I:(DE-2719)1810003$$kAG Prüß$$lAutoimmune Encephalopathies$$x0
000280248 980__ $$ajournal
000280248 980__ $$aVDB
000280248 980__ $$aUNRESTRICTED
000280248 980__ $$aI:(DE-2719)1810003
000280248 9801_ $$aFullTexts